Elevated VEGF-C expression was reported in patients with prostatic carcinoma and oesophageal squamous cell carcinoma (Tsurusaki et al, 1999; Kitadai et al, 2001) but is controversial with regard to AML patients (Fielder et al, 1997; Dias et al, 2002; Loges et al, 2005). Here, VEGFC is linked to acute myeloid leukemia.